- Research article
- Open Access
- Open Peer Review
Conventional and molecular epidemiology of Tuberculosis in Manitoba
© Blackwood et al; licensee BioMed Central Ltd. 2003
- Received: 11 June 2003
- Accepted: 13 August 2003
- Published: 13 August 2003
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
To describe the demographic and geographic distribution of tuberculosis (TB) in Manitoba, thus determining risk factors associated with clustering and higher incidence rates in distinct subpopulations.
Data from the Manitoba TB Registry was compiled to generate a database on 855 patients with tuberculosis and their contacts from 1992–1999. Recovered isolates of M. tuberculosis were typed by IS6110 restriction fragment length polymorphisms. Bivariate and multivariate logistic regression models were used to identify risk factors involved in clustering.
A trend to clustering was observed among the Canadian-born treaty Aboriginal subgroup in contrast to the foreign-born. The dominant type, designated fingerprint type 1, accounts for 25.8% of total cases and 75.3% of treaty Aboriginal cases. Among type 1 patients residing in urban areas, 98.9% lived in Winnipeg. In rural areas, 92.8% lived on Aboriginal reserves. Statistical models revealed that significant risk factors for acquiring clustered tuberculosis are gender, age, ethnic origin and residence. Those at increased risk are: males (p < 0.05); those under age 65 (p < 0.01 for each age subgroup); treaty Aboriginals (p < 0.001), and those living on reserve land (p < 0.001).
Molecular typing of isolates in conjunction with contact tracing data supports the notion of the largest ongoing transmission of a single strain of TB within the treaty-status population of Canada recorded to date. This data demonstrates the necessity of continued surveillance of countries with low prevalence of the disease in order to determine and target high-risk populations for concentrated prevention and control measures.
- Mycobacterium tuberculosis
- DNA fingerprinting
Tuberculosis (TB) has infected one-third of the world population and kills three million people each year. Globally, TB is considered the most common cause of death from a single infectious organism, Mycobacterium tuberculosis [1–3]. Canadians have a long history of suffering tremendously from TB. In the 19th century, one fifth of Canadians were infected with this disease and large numbers died. In the beginning of the 20th century, the mortality rate among Aboriginal people of Saskatchewan and Alberta reached as high as 9,000 per 100,000 [4, 5].
Improvements in socioeconomic conditions, public health services, drug therapy and medical surveillance in Canada markedly reduced the mortality rate [0.4 per 100,000 by 1987] and overall incidence rates (5.9 per 100,000 by 1998) . However, certain groups in Canada are at higher risk for acquiring TB, such as the Aboriginal population (defined as status and non-status Indian, Metis, Inuit, and Innu), foreign-born individuals from countries with high prevalence rates of TB, the homeless and the HIV-infected population . In 1998, the incidence rate among non-Aboriginal Canadians was 1.5 per 100,000; in contrast, the status Indian, total Aboriginal and foreign-born population had incidence rates of 35.4, 22.5 and 21.4 per 100,000 respectively . Furthermore, the proportion of TB cases reported in Canada from the foreign-born population has increased, from 35% in 1980 to 64% in 1998 . In an attempt to eliminate tuberculosis in Canada, the Tuberculosis Prevention and Control Unit of Health Canada implemented guidelines recommended by the World Health Organization in 1997 . Despite adoption of these guidelines, incidence rates of TB are still high in certain geographic and demographic zones, making elimination of the disease by recommended time periods put forth by Health Canada an increasingly difficult goal [6, 8]. Currently, incidence rates in Canada have leveled off and remain fairly constant due to these sustaining population subgroups.
The majority (75%) of TB patients in Canada live in three provinces: Ontario, Quebec and British Columbia. Furthermore, 90% of all TB cases in the country attributed to the foreign-born population reside in these provinces . In Manitoba however, the composition of TB patients is distinctly different: the majority of TB cases are among Canadian-born, with the highest incidence among treaty Aboriginals (48.4 per 100,000 overall, with rates as high as 496.3 per 100,000 in select communities [10, 11].
These distinct epidemiological patterns merited a further examination. Consequently, in this study, both conventional in conjunction with molecular methods were used to describe the epidemiology of tuberculosis in Manitoba from 1992 to 1999. The objectives of the study were to describe subgroups within Manitoba at high risk for developing TB, and to define risk factors and possible reasons for the ongoing transmission in order to better target prevention and control programs.
Manitoba has a population of 1.14 million (Statistics Canada, 1996). 78.1% are Canadian-born (CB) non-treaty, 8.9% are treaty Aboriginals, and the remainder is foreign-born (FB) [12, 13]. It is unknown how many Aboriginal individuals have not claimed treaty status. All diagnosed cases of tuberculosis in Manitoba are registered in the Manitoba Central Tuberculosis Registry (MCTR) at the Health Sciences Center (HSC) in Winnipeg. Case finding in Manitoba is done by clinical diagnosis of symptomatic patients and by contact tracing. Administered treatment is drug therapy of a combination of first line antituberculosis drugs: rifampin, isoniazid, pyrazinamide, ethambutol, and/or streptomycin. Direct observed therapy (DOT) verifies a completed course of treatment. Ninety-five percent of patients under DOT complete treatment in Manitoba .
Data on all TB patients and identified contacts from January 1, 1992 to December 31, 1999 was obtained from the MCTR. Data fields such as the patient's unique identifier number, date of birth, birthplace, sex, country of birth, postal code, origin (CB treaty / non-treaty or FB), date of diagnosis, case finding method, TB status (new, active or relapse), BCG status, year of landing (foreign patients), smear results, culture results, TB DNA fingerprint type, drug resistance, chest X-rays and cavity status were extracted from the patient records and the information was entered into a database. This data set did not include patient name, allowing data analysis while maintaining the patient confidentiality. Specimens were collected by designated medical staff at the Respiratory Clinic, HSC, and other health care centers in Manitoba. The collected samples were sent to the Clinical Microbiology Laboratory at HSC for isolation and identification of M. tuberculosis. The Accuprobe M. tuberculosis complex kit (Gen-Probe Incorporated, San Diego, CA, USA) was used to identify M. tuberculosis in the clinical samples. Samples were subsequently processed for DNA sub-typing according to the internationally standardized methodology of IS6110 restriction fragment length polymorphisms (RFLP) . Procedures outlined by Small et. al. to minimize the possibility of cross-contamination  was strictly adhered to by staff at the HSC and no evidence of cross-contamination was observed.
All gel pictures containing the IS6110 RFLP patterns were analyzed to determine clustering using Molecular Analyst® Software Fingerprinting version 1.12, BioRad, Hercules, CA, USA. Clustering establishes groups of patients from which isolates with identical or near identical fingerprints are found and are likely to be linked epidemiologically . Clustered cases were identified by searching each fingerprint against the created database containing all other patterns over the eight-year period using the Dice coefficient with 1.5% position tolerance and verified visually. Isolates with identical patterns or differing by a single band were considered the same . All created databases were stored in Microsoft Access® and linked together utilizing the MCTR unique identifier numbers.
Bivariate logistic regression analysis of risk factors associated with clustering.
n = 426 (%)
n = 203 (%)
0 to 14
15 to 24
25 to 44
45 to 64
Site of Infection
Multivariate logistic regression analysis of risk factors associated with clustering
n = 426 (%)
n = 203 (%)
0 to 14
15 to 24
25 to 44
45 to 64
The age distribution of TB cases varies between the three population subgroups. For the treaty status subgroup, the incidence in the oldest (65+) age group was 17.3 times that in the youngest (0–14) age group, whereas this ratio was 10.9 for the non-treaty population, and only 1.3 for the foreign-born population (Figure 3).
Molecular typing and clustering of cases
Isolates of M. tuberculosis were obtained from a total of 629 patients (73.6%) for molecular typing to establish clustering. The remaining balance of cases were diagnosed by means other than microbiological and thus no culture was available for sub-typing. The patient characteristics of these unavailable isolates were compared to those available to observe any significant differences that may affect estimation of clustering. The distribution of patients was roughly the same for both and was deemed not significant. Fingerprint patterns of less than six RFLP bands were observed in 15 isolates. These fingerprints did not cluster, and therefore secondary sub-typing of these isolates, i.e. spoligotyping, was not performed .
Risk Factor Analysis
Analysis of risk factors for clustering using both bivariate and multivariate analysis is summarized in tables 1 and 2. Significant independent risk factors for clustering included gender, age, geographic residence and ethnic origin. Males are twice as likely to develop clustered TB than females (table 2). Treaty status patients are at four times higher risk of developing clustered TB than those without treaty status (reference subgroup), while in comparison, foreign-born patients are at one-quarter the risk for developing clustered TB compared to the reference population. TB patients in the four age groups under age 65 had risks of developing clustered TB that ranged from 1.5 to 3.3 times that of those over the age of 65 (table 2). Residence on a reserve was significant in the bivariate analysis: these patients have a five times higher risk of having clustered TB than the patient group that lives in Winnipeg. In the multivariate model, however, controlling for the other variables revealed that residence is not a significant independent risk factor, although living in a rural non-reserve area is protective (table 2). Finally, there was no evidence that patients with pulmonary TB had a higher risk of developing clustered TB than those with extra pulmonary TB.
The largest cluster contained 162 cases that displayed FP1. Contact investigations were indicated on 121 of these cases, determining a total of 2195 contacts. 145 of those contacts presented with disease. Of the 145 contacts, 92 (63.5%) harbored the FP1 strain of TB. 4 (2.8%) had a fingerprint type other than FP1, and the remainder of cases did not have isolates available for typing purposes. Most exposures were from family members (57.5%)or friends (24.5%) in the home (71.7%). Preliminary social network analysis using software packages Ucinet and Pajek revealed the spread of TB from Winnipeg to reserve land and vice versa.
The major single contributor to the current burden of incident cases is the treaty status subpopulation. The treaty subgroup, with 44.4% of all tuberculosis cases in Manitoba, comprises the largest group of cases, despite the fact that they represent only 8.9% of Manitoba's population. This figure is probably an underestimate of all Aboriginal cases due to an unknown number of Aboriginal individuals who have not claimed treaty status. Moreover, the incidence rate of TB among the treaty status population (48.4 per 100,000) was higher than both the provincial rate (9.2 per 100,000) and the national rate of (5.9 per 100,000) by five and eight times respectively. Certain northern First Nation communities have TB incidence rates that are markedly elevated (up to 496.3 per 100 000 person-years). Statistical analysis showed the treaty subgroup to be at relatively high risk for the development of TB, with significant independent risk factors for clustering to include male gender, treaty status, and under age 65.
More than 75% of the treaty status population group was clustered together by the FP1 strain. Contact tracing revealed only 92 (57%) confirmed epidemiological links within this cluster, living in both Winnipeg and reserve land. Although using both molecular and conventional techniques verifies that linked cases are most likely linked, there are limitations to using these techniques . Firstly, transmission can occur through brief, casual contacts, leading to patients having the same fingerprint pattern, yet no definable connection. Secondly, identical RFLP patterns can be obtained from patients that are not linked through recent transmission/reinfection, but due to reactivation. Thirdly, the strain can be inherent in a population, with an unidentifiable source.
However, as clustering is assumed to reflect recent transmission within in a population [16, 19], supported by the considerable transmission between family and friends as illustrated by contact investigations, it is highly probable that there is an ongoing, propagating TB outbreak in this subpopulation. The presence of a high percentage of respiratory tuberculosis cases and the large number of positive smear results (data not shown) among FP1 patients suggests that TB in this population subgroup may be transmitted more efficiently than in other subgroups. Potential factors contributing to increased risk in this subpopulation include: relative poverty, crowded housing, dense social networks, delays in diagnosis and treatment, increased susceptibility to infection due to poorer health status, and increased prevalence of substance abuse. Data on these variables was not available for analysis in the present study. In addition, while the HIV positive group was emerging as an at-risk group for TB in the US, it has not yet been recognized as a risk group in Canada . Thus, the HIV status of tuberculosis patients was not routinely determined in Manitoba until 1997; therefore, complete data on this variable was not available for the current study .
The reason for the dominance of FP1 remains unknown, although it has been speculated that perhaps this strain was the first strain introduced to Manitoba. Host genetics, strain virulence or a combination thereof may play a role [22, 23]. Routine BCG administration to treaty status infants could have further fostered the natural selection of FP1 by increasing body protection against other susceptible strains through selective immunity. While it is difficult to disentangle social, economic and host risk factors from our analysis, we speculate that this particular strain may be more virulent than other strains introduced to the population. It is possible that this strain shares some features in common with putatively 'hyper virulent' strains CDC 1551 and/ or HN878 [24, 25]. Bacterial virulence factors, their expression, regulation and mutation, and host immune system evasion mechanisms may play a role, and this remains to be studied .
Winnipeg and nine Aboriginal reserves of northern Manitoba appear to be the two reservoirs that maintain the bulk of clustered TB cases. Patients on reserves were found more than six times as likely to have clustered TB compared to patients in Winnipeg using bivariate analysis. Sixty percent of Manitoba's entire population lives in Winnipeg and there is considerable mobility between Winnipeg and the reserve communities. Since neither geography nor physical distance can provide a barrier to stop the spread of this disease, the types of contact relationships are important factors in elucidating the spread of TB and differentiating active transmission versus reactivation.
The epidemiological separation between CB and FB tuberculosis cases is the result of many different characteristics. The dominance of unique (non-clustered) fingerprints among foreign-born individuals suggests that these patients may have contracted the disease outside the province and have subsequently imported tuberculosis into Manitoba through immigration. This was found true of imported TB in province of Alberta . The age distribution of cases in the foreign-born subgroup reflects the age distribution of immigrants, some of whom for unknown reasons progress to active TB after arrival into Canada. New arrivals into the country may for some time have limited close contact with Canadian-born individuals, which reduces the chance of spread from immigrants to the CB population. The small amount of clustering that does occur in the FB subpopulation may be explained largely by activation of infections acquired from common sources in the foreign country of origin. In Manitoba, FB TB patients reside largely in the Winnipeg area and spread of the disease from FB patients to CB individuals is very limited (data not shown).
While the foreign-born population may not seem to be actively spreading TB in Manitoba, incidence rates are still relatively high, and the number of FB cases reported annually is increasing. Screening procedures for immigrating individuals from countries with high or low prevalence of TB need further examination for effectiveness and cost-effectiveness .
In the present study, information derived from both conventional and molecular epidemiology methods allowed assessment of current trends and risk factors for subpopulation groups in Manitoba for contracting TB. Retrospective studies such as this one using stored RFLP data have shown invaluable to identify both clinical and epidemiological risk factors for clustering, and have been used extensively to study other populations within San Francisco, New York and the Netherlands [17, 19, 28, 29]. This information helps assess the effectiveness and possible limitations of the Manitoba TB control programs. Elimination of TB has been defined as less than 1 case per 100,000 population per year [6, 8]. By this standard, recent transmission to Canadian-born non-treaty status individuals has been nearly eliminated, reaching incidence rates of only 3.3 per 100,000. Complete elimination of TB in Manitoba has been targeted for 2010, with 5% reduction in incidence per year goal [6, 8], but with the high incidence rates in the remaining two sub-populations, this will be a difficult task. Targeting and intensifying control measures in the immigrant and treaty status Aboriginal subpopulations should be a priority in striving for the goal of tuberculosis elimination in Manitoba.
- Fanning EA: Globalization of tuberculosis. CMAJ. 1998, 158: 611-612.PubMedPubMed CentralGoogle Scholar
- Piheu JA: Tuberculosis 2000: problems and solutions. Int J Tuberc Lung Dis. 1998, 2: 696-703.Google Scholar
- Raviglione MC, Snider DE, Kochi A: Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA. 1995, 273: 220-226. 10.1001/jama.273.3.220.View ArticlePubMedGoogle Scholar
- Grzybowski S, Allen EA: Tuberculosis: 2. History of the disease in Canada. CMAJ. 1999, 160: 1025-1028.PubMedPubMed CentralGoogle Scholar
- Wherret GJ: Tuberculosis in Canada. Ottawa: Royal Commission on Health Services. 1964Google Scholar
- Canada Communicable Disease Report. Supplement: Proceedings of the national consensus conference on tuberculosis. Health Canada. 1997, 24S2:Google Scholar
- Long R, ed: Canadian Tuberculosis Standards. Canadian Lung Association and Health Canada. 2000, 5Google Scholar
- Health Canada: Tuberculosis in the First Nations, 1999. Health Canada, Canada. 1999, (Cat.H35-4/7-1999E) (ISBN 0-662-30044-0)Google Scholar
- Long R, Njoo H, Hershfield E: Tuberculosis: 3. Epidemiology of the disease in Canada. CMAJ. 1993, 160: 1185-1190.Google Scholar
- Al-Azem A, Abomoelak B, Wolfe J, MacMorran J, Hershfield E, Kabani A: Tuberculosis in Manitoba: Conventional and molecular epidemiology (1992–1999) [abstract]. Public Health Poster Session (ATS). 2000, CDC-NCHSTP-DTBEGoogle Scholar
- Al-Azem A, Abomoelak B, Wolfe J, MacMorran J, Hershfield E, Kabani A: Rural and localized tuberculosis outbreaks in Manitoba (1992–1999) [abstract]. Public Health Poster Session (ATS). 2000, CDC-NCHSTP-DTBEGoogle Scholar
- Dimensions Series: Portrait of Aboriginal Population in Canada. Ottawa, ON: Statistics Canada. 1999, [94F0011XCB]Google Scholar
- Live Database 1992–1997, Indian Registry System, Indian and Northern Affairs Canada. Manitoba Region.Google Scholar
- van-Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Hermans P, Martin C, McAdam R, Shinnick TM: Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993, 31: 406-409.PubMedPubMed CentralGoogle Scholar
- Small PM, McClenny NB, Singh SP, Schoolnik GK, Tompkins LS, Mickelsen PA: Molecular strain typing of Mycobacterium tuberculosis to confirm cross- contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures. J Clin Microbiol. 1993, 31: 1677-82.PubMedPubMed CentralGoogle Scholar
- Rhee JT, Tanaka MM, Behr MA, Agasino CB, Paz EA, Hopewell PC, Small PM: Use of multiple markers in population-based molecular epidemiologic studies of tuberculosis. Int J Tuberc Lung Dis. 2000, 4: 1111-1119.PubMedGoogle Scholar
- Shafer RW, Small PM, Larkin C, Singh SP, Kelly P, Sierra MF, Schoolnik G, Chirgwin KD: Temporal trends and transmission patterns during the emergence of multidrug-resistant tuberculosis in New York City: a molecular epidemiologic assessment. J Infect Dis. 1995, 171: 170-76.View ArticlePubMedGoogle Scholar
- Al-Azem A, Abomoelak B, Wolfe J, MacMorran J, Hershfield E, Kabani A: The impact of foreign-born tuberculosis in Manitoba (1992–1999) [abstract]. Public Health Poster Session (ATS). 2000, CDC-NCHSTP-DTBEGoogle Scholar
- Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, Schechter GF, Daley CL, Schoolnik GK: The epidemiology of tuberculosis in San Francisco. A population based study using conventional and molecular methods. N Eng J Med. 1994, 330: 1703-1709. 10.1056/NEJM199406163302402.View ArticleGoogle Scholar
- Gaudette LA, Ellis E: Tuberculosis in Canada: a focal disease requiring distinct control strategies for different risk groups. Tuber Lung Dis. 1993, 74: 244-53.View ArticlePubMedGoogle Scholar
- Yuan L, Carew M, Kwavnick B, Trudel N: Medical services branch tuberculosis program and epidemiologic review. Health Canada, Canada. 1999Google Scholar
- Stead WW: Variation in vulnerability to tuberculosis in America today: random, or legacies of different ancestral epidemics?. Int J Tuberc Lung Dis. 2001, 5: 807-814.PubMedGoogle Scholar
- Kato-Maeda M, Bifani PJ, Kreiswirth BN, Small PM: The nature and consequence of genetic variability within Mycobacterium tuberculosis. J Clin Invest. 2001, 107: 533-537.View ArticlePubMedPubMed CentralGoogle Scholar
- Manca C, Tsenova L, Barry CE, Bergtold A, Freeman S, Haslett PA, Musser JM, Freedman VH, Kaplan G: Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol. 1999, 162: 6740-46.PubMedGoogle Scholar
- Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, Barry CE, Freedman VH, Kaplan G: Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc Natl Acad Sci USA. 2001, 98: 5752-57. 10.1073/pnas.091096998.View ArticlePubMedPubMed CentralGoogle Scholar
- Cowie RL, Sharpe JW: Tuberculosis among immigrants: interval from arrival in Canada to diagnosis. A 5-year study in southern Alberta. CMAJ. 1998, 158: 599-602.PubMedPubMed CentralGoogle Scholar
- Schwartzman K, Menzies D: Tuberculosis screening of immigrants to low-prevalence countries: a cost-effectiveness analysis. Am J Respir Crit Care Med. 2000, 161: 780-789.View ArticlePubMedGoogle Scholar
- Jasmer RM, Hahn JA, Small PM, Daley CL, Behr MA, Moss AR, Creasman JM, Schecter GF, Paz EA, Hopewell PC: A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991–1997. Ann Intern Med. 1999, 130: 971-978.View ArticlePubMedGoogle Scholar
- Borgdorff MW, Nagelkerke N, van Soolingen D, de Haas PE, Veen J, van Embden JD: Analysis of tuberculosis transmission between nationalities in the Netherlands in the period 1993–1995 using DNA fingerprinting. Amer J Epidem. 1998, 147: 187-195.View ArticleGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/3/18/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.